Skip to main content

Table 2 Outcomes from lymphoedema treatment using the Glasgow Benefit Inventory scores

From: Using the Glasgow Benefit Inventory questionnaire to quantify the health benefits of lymphoedema treatment in patients with head and neck cancer

Patient Glasgow Benefit Inventory total score Glasgow Benefit Inventory general benefit score Glasgow Benefit Inventory physical benefit score Glasgow Benefit Inventory social benefit score
Patient 1 −50.0 −41.7 −50.0 −83.3
Patient 2 −19.4 −16.7 −16.7 −33.3
Patient 3 0.0 0.0 0.0 0.0
Patient 4 + 5.6 + 4.2 0.0 + 16.7
Patient 5 0.0 0.0 0.0 0.0
Patient 6 + 16.7 + 12.5 + 33.3 + 16.7
Patient 7 + 13.9 + 12.5 + 50.0 −16.7
Patient 8 −2.8 0.0 + 16.7 −33.3
Patient 9 + 11.1 + 20.8 + 16.7 −33.3
Patient 10 + 8.3 + 12.5 0.0 0.0
Patient 11 + 16.7 + 20.8 + 83.3 − 66.7
Patient 12 + 25.0 + 25.0 + 16.7 + 33.3
Patient 13 + 13.9 + 16.7 0.0 + 16.7
Patient 14 + 30.6 + 29.2 + 33.3 + 33.3
Patient 15a + 38.9 + 38.9
Average + 7.2 + 9.0 + 13.1 −10.7
  1. a This patient did not complete the questionnaire completely and has been excluded from calculation of the physical benefit and social benefit subscale scores
\